Doege-Potter syndrome associated to metastatic solitary fibrous tumor
Matheus de Oliveira Andrade; Nathália da Cruz de Sousa; Paulo Siqueira do Amaral; Samantha Cabral Severino da Costa; Luiz Guilherme Cernaglia Aureliano de Lima; Delmar Muniz Lourenço Júnior; Olavo Feher
Abstract
Keywords
References
1 de Pinieux G, Karanian M, Le Loarer F, et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One. 2021;16(2):e0246958.
2 Olson NJ, Linos K. Dedifferentiated solitary fibrous tumor: a concise review. Arch Pathol Lab Med. 2018;142(6):761-6.
3 Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180-5.
4 Tariq MU, Din NU, Abdul-Ghafar J, Park YK. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagn Pathol. 2021;16(1):32.
5 Khowaja A, Johnson-Rabbett B, Bantle J, Moheet A. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review. BMC Endocr Disord. 2014;14:49.
6 Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94(4):1057-68.
7 Georgiesh T, Boye K, Bjerkehagen B. A novel risk score to predict early and late recurrence in solitary fibrous tumour. Histopathology. 2020;77(1):123-32.
8 Ishihara H, Omae K, Iizuka J, et al. Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis. Oncol Lett. 2016;12(1):479-84.
9 Le Jeune S, Des Guetz G, Bihan H, Cohen R, Coindre JMMJ, Mourad JJ. Refractory hypoglycemia controlled by sorafenib in solitary fibrous tumor. J Clin Oncol. 2013;31(9):e118-21.
10 Mohammed T, Ozcan G, Siddique AS, Araneta RN 3rd, Slater DE, Khan A. Doege-Potter syndrome with a benign solitary fibrous tumor: a case report and literature review. Case Rep Oncol. 2021;14(1):470-6.
11 Smrke A, Thway K, H Huang P, Jones RL, Hayes AJ. Solitary fibrous tumor: molecular hallmarks and treatment for a rare sarcoma. Future Oncol. 2021;17(27):3627-36.
12 Kawai S, Ariyasu H, Uraki S, et al. Imbalanced expression of IGF2 and PCSK4 is associated with overproduction of big IGF2 in SFT with NICTH: a pilot study. J Clin Endocrinol Metab. 2018;103(7):2728-34.
13 Krishnan L, Clark J. Non-islet cell tumour hypoglycaemia. BMJ Case Rep. 2011;2011:bcr0220113914.
14 Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab. 2014;99(3):713-22.
15 Tsuro K, Kojima H, Okamoto S, et al. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-II-producing solitary fibrous tumor. Intern Med. 2006;45(8):525-9.
16 de Boer J, Jager PL, Wiggers T, et al. The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. Int J Clin Oncol. 2006;11(6):478-81.
17 Sawka A, Toh D. Biochemical challenge: difficult management of recurrent hypoglycaemia in the setting of a massive solitary fibrous tumour of the liver. Intern Med J. 2018;48(6):744-6.
18 Bailly C, Bichali Alroumani M, Douane F, Ansquer C, Drui D. Metastatic solitary fibrous tumor with Doege-Potter Syndrome: hypoglycemia treated by 90Y radioembolization. Clin Nucl Med. 2018;43(3):e93-5.
19 Otake S, Kikkawa T, Takizawa M, et al. Hypoglycemia observed on continuous glucose monitoring associated with IGF-2-producing solitary fibrous tumor. J Clin Endocrinol Metab. 2015;100(7):2519-24.
Submitted date:
10/23/2022
Accepted date:
11/18/2022
Publication date:
12/13/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email